搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
Endocrinology Advisor
1 天
Risk for Pancreatitis Does Not Increase With Tirzepatide
Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.
StarsInsider on MSN
6 天
Page settings
In 2024, the news of several US deaths from the mosquito-borne virus known as eastern equine encephalitis (EEE) once again ...
2 天
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
Miami's Community Newspapers
12 小时
Should you get on the Ozempic bandwagon?
A dietetics professor explains who should and should not embrace the latest weight-loss drugs. Holiday weight gain hits home ...
10 小时
Novo Nordisk: From Peak Performance To Needing A Booster Shot
I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...
Medscape
1 天
New Weight Loss Drugs May Fight Obesity-Related Cancer, Too
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
Medpage Today on MSN
2 天
T1D Islet Cell Transplant; 50K Processed Foods Ranked; Obesity and Childhood Cancers
Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation without ...
pancan
6 天
ABOUT Pancreatic Cancer
More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
6 天
Can Ozempic damage your optic nerve? Here’s what doctors say about a new study
A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...
5 天
Beta Bionics Aims For IPO To Cover Heavy Losses
Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈